Low penetrance of mutant alleles such as BMPR23,4 indicates that factors in addition to BMPRII deficiency are required to induce PAH in most cases and underscores the importance of therapeutic approaches targeting multiple disease mediators in combination. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.